Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
ADAM metallopeptidase domain 19 (ADAM19) is a single pass transmembrane multi domain metalloprotease encoded by ADAM19 gene. This protein localizes to plasma membrane of multiple cell populations. ADAM19 possesses large extracellular region containing pro domain, metalloprotease catalytic domain plus additional disintegrin like and cysteine rich modules, one transmembrane helix and a cytoplasmic C terminal tail. Extracellular domains face extracellular environment, while cytoplasmic tail resides on intracellular side of plasma membrane. Newly synthesized ADAM19 polypeptide folds inside endoplasmic reticulum. The N terminal pro domain keeps metalloprotease catalytic site in inactive state until pro domain gets removed through proteolytic maturation event within secretory compartments. Only pro domain processed protein reaches cell surface with competent protease activity. Different cell types exhibit variable ADAM19 expression magnitude. Misfolded polypeptide fails to pass secretory pathway quality control and cannot traffic toward plasma membrane. Proteolytic maturation efficiency varies among cell types and shapes final abundance of active ADAM19 at cell surface.
After pro domain removal, mature ADAM19 metalloprotease domain gains catalytic competence and executes limited cleavage proteolysis toward selected substrate proteins located at cell surface membrane. Many physiological substrates are other transmembrane proteins; ADAM19 cuts substrate polypeptide at extracellular juxtamembrane region. This cleavage event releases soluble extracellular domain fragments of substrate molecules into extracellular space. Disintegrin like and cysteine rich extracellular modules contribute toward substrate recognition and help define substrate selectivity. Other ADAM family paralogs share similar multi domain architecture but show distinct substrate preference profiles and cannot fully recapitulate ADAM19 target protein spectrum. Variation in ADAM19 abundance changes total number of active protease units present at cell surface and modulates overall cellular capacity for juxtamembrane substrate shedding. Mutation inside metalloprotease catalytic site abolishes proteolytic turnover without necessarily destroying substrate recognition capability. Alteration of disintegrin cysteine rich segments can change substrate selection pattern while preserving catalytic site function. Changes to cytoplasmic tail sequence modify intracellular partner protein interactions without directly influencing extracellular protease catalytic activity.
Fig. 1 Domain architecture of human ADAM19 transmembrane protease. The inactive pre‑mature form carries an N‑terminal pro‑domain maintaining latency. Pro‑domain cleavage generates enzymatically active mature ADAM19, consisting of metalloprotease, disintegrin‑like, cysteine‑rich, EGF‑like, transmembrane and cytoplasmic‑tail modules.1
The biological functions of ADAM19 are focused on pro domain mediated protease latency control, cell surface juxtamembrane substrate proteolysis and multi module dependent target substrate recognition:
Creative Biolabs offers purified ADAM19 membrane samples via standardized preparation workflows, including full length ADAM19 constructs and isolated extracellular multi domain variants. Isolated extracellular fragments may not support complete pro domain maturation coupled with membrane context dependent juxtamembrane cleavage related behaviours, while full length constructs may be suited for ADAM family transmembrane metalloprotease associated research. All samples receive routine quality screening, and functional relevant observation may only be carried out with full length samples under simulated membrane environments. All sample batches follow unified processing standards to maintain consistent structural features for comparative laboratory analysis across separate test groups.
Not finding the membrane protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable ADAM19 expression cell models with varied expression levels, applicable to transmembrane multi domain metalloprotease structural characteristic observation and cell surface juxtamembrane shedding related research. Sample evaluation includes sustained target expression detection and preliminary intermolecular interaction associated observation, which can support comparative analysis of protease associated behaviours under different expression statuses. These cell systems can be matched with diverse laboratory analysis schemes to observe changes of substrate cleavage efficiency under different target expression abundances.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Antibody reagents targeting ADAM19 are generated via mature protein preparation workflows, compatible with multiple routine laboratory detection methods for cellular localization profiling and molecular complex identification, to support systematic analysis of ADAM19 distribution and ADAM protease associated molecular complexes across diverse laboratory research setups. The antibody series can cooperate with other common laboratory detection reagents to complete multi dimensional observation of target distribution inside tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for ADAM19 research:
ADAM19 may function as transmembrane ADAM family metalloprotease and participate in pro domain dependent protease maturation and juxtamembrane substrate proteolytic cleavage.
ADAM19 expression status may influence cell surface substrate shedding capacity, serving as a major regulatory mediator of ADAM protease associated biological processes.
No, all ADAM19 related products and services are strictly for research use only, not intended for clinical related operations. All material designs and functional tests are only optimized for basic laboratory research scenarios, without matching clinical application standards.
Offerings include full length ADAM19 membrane protein, target specific recombinant antibodies and adjustable expression cell research models, supporting ADAM family transmembrane metalloprotease research.
Laboratory observation schemes may include ADAM protease substrate interaction related tests to analyse protease associated behaviours under simulated cellular environments.
